CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
American Bio Medica Corporation Company Snapshot
American Bio Medica Corporation operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares American Bio Medica with three other companies in this sector in the United States: Roka Bioscience Inc (2015 sales of $5.99 million of which 100% was Diagnostic Substance), Aeglea Bio Therapeutics Inc ($6.09 million of which 100% was Pharmaceutical), and Globeimmune Inc ($6.46 million ).

Sales Analysis. During the year ended December of 2015, sales at American Bio Medica were $6.32 million. This is a decrease of 13.3% versus 2014, when the company's sales were $7.29 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
American Bio Medica Corporation
  Stock Performance Chart for American Bio Medica Corporation
 
  Stock Data: Recent Stock Performance:
  Current Price (11/29/2016): .11
(Figures in U.S. Dollars)
1 Week -12.5%   13 Weeks -12.5%  
4 Weeks n/a   52 Weeks -19.8%  
 
American Bio Medica Corporation Key Data:
  Ticker: ABMC Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 6,317,000
(Year Ending Jan 2016).
Employees: 80
  Currency: U.S. Dollars Market Cap: 3,414,696
  Fiscal Yr Ends: December Shares Outstanding: 28,458,173
  Share Type: Common Closely Held Shares: 11,454,632
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.